H|T: The Healthtech Times – Canadian pharmaceutical research spending dropped in 2022
Plus: Myanmar Molecular seeks Health Canada approval.
Plus: Myanmar Molecular seeks Health Canada approval.
Ziing looks to expand its Canadian delivery network with second acquisition this year.
MedReddie, SkyAcres, and Nimble Science represent Canada in the class of 2024.
Plus: US resistance has Shein eyeing UK to IPO.
Wealthsimple, Shopify, Ada, Knix execs part of contingent backing studio run by CEO Rachel Zimmer.
Plus: Six months after launch, Torontoâs Ideogram secures $80 million.
Startup says one of its chips can hold an entire large AI model without requiring external memory.
Plus: How Flinks is building middleware for open banking.
Autodesk, Electronic Arts, and BenchSci are looking to beef up their AI teams.
Plus: Abridge raises $150 million to increase the speed and accuracy of medical note-taking.
The minds behind Ross Intelligence are back.
Plus: Shopifyâs green strategy gamble, DeliveryHero abandons Foodpanda sale talks.
The fundraise comes just six months after its $22.3-million seed round.
Power claims over 600,000 patients used Power to discover clinical trials last year.
Following 2023 layoffs, Miller Wright must steer Certnâs global operations through a âtransformation year.â